Brendan Rauw

BRENDAN RAUW

Brendan Rauw brings 20 years of management and leadership experience with life science companies and startups, including market assessment, company formation, licensing and business development, intellectual property strategy, research and development, organizational design, marketing effectiveness, salesforce optimization, and operations.
Previously, Brendan served as Vice President of Technology Transfer and Business Development at Oregon Health and Science University (OHSU). In this role, they increased the commercialization of OHSU’s intellectual property and research, and introduced an Entrepreneur-in-Residence program. Prior to joining OHSU, Brendan was Associate Vice Chancellor and Executive Director of Entrepreneurship at UCLA, responsible for leading the office and overseeing diverse programs to encourage innovation and entrepreneurship. While at UCLA, they founded Westwood Technology Transfer, an independent 501(c)(3) formed to manage intellectual property on behalf of the university.
Overseas, Brendan lived in Saudi Arabia establishing the King Abdullah University of Science and Technology (KAUST), a private university with a $20 billion endowment. Within the Innovation & Economic Development department, Brendan managed seed investments and negotiated intellectual property agreements with 42 global collaborative partners. Brendan led the $250K initial investment in NOMADD Desert Solar Solutions, the first spinout from KAUST. Brendan was also Portfolio Director and member of the senior leadership team of Columbia Technology Ventures in New York, responsible for Columbia University’s intellectual property investment and management.
Brendan came to university technology transfer from a background of management consulting and entrepreneurship. He was a project leader in the New York office of the Boston Consulting Group, advising major private equity and biopharmaceutical companies on topics such as corporate acquisitions and innovation strategy, including two $40+ billion acquisitions. Brendan also worked in Corporate Development with Genzyme Corporation.
Brendan has been a founding member of multiple startups. They led business development for Celator Pharmaceuticals up to their Series A, developing the patent strategy and licensing university patent rights, and was a member of the founding team of Claros Diagnostics, a semi-finalist in the MIT $50K competition that was acquired for $50M.
Brendan serves on the Board of Directors of the Oregon Bioscience Association, the Headwaters Council for The Freshwater Trust, and as a Biomentor for OTRADI. Brendan earned an undergraduate degree with high honors in biology from Harvard College, and an MBA from Harvard Business School on the John H. McArthur Fellowship.

Back to the Team